Caribou Biosciences, Inc. - Common Stock (CRBU)

Historical Holders from Q3 2021 to Q3 2025

Symbol
CRBU on Nasdaq
CUSIP
142038108
Type / Class
Equity / Common Stock
Shares outstanding
92.2M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
37M
Holdings value
$86.3M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
114
Number of buys
37
Number of sells
-72
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Caribou Biosciences, Inc. - Common Stock (CRBU)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Haurwitz Rachel E. 5% $4.24M 4.72M Rachel E. Haurwitz Apr 22, 2025
VANGUARD GROUP INC 4.86% $4.07M 4.52M The Vanguard Group Mar 31, 2025
BANK OF AMERICA CORP /DE/ 2.2% $1.76M 1.95M BANK OF AMERICA CORP /DE/ Dec 31, 2024
BlackRock, Inc. 2% -68.6% $1.44M -$3.46M 1.84M -70.6% BlackRock, Inc. Jun 30, 2025

Institutional Holders of Caribou Biosciences, Inc. - Common Stock (CRBU)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 37M $86.3M -$6.93M $2.33 114
2025 Q2 40.8M $52M -$11.2M $1.26 129
2025 Q1 50.1M $45.8M -$8.74M $0.91 127
2024 Q4 58.1M $92.4M +$1.34M $1.59 130
2024 Q3 52.2M $102M -$1.22M $1.96 124
2024 Q2 53M $87M -$69.1M $1.64 136
2024 Q1 66.7M $343M -$10.2M $5.14 150
2023 Q4 46.6K $269K -$426K $5.81 2
2023 Q3 70.8M $338M +$132M $4.78 125
2023 Q2 43.7M $185M -$6.83M $4.25 115
2023 Q1 44.9M $238M +$6.93M $5.31 124
2022 Q4 43M $270M -$3.25M $6.28 129
2022 Q3 42M $443M +$59.3M $10.55 108
2022 Q2 36.7M $199M +$12.5M $5.43 112
2022 Q1 34.8M $320M +$32.5M $9.18 100
2021 Q4 31M $463M -$1.25M $15.09 89
2021 Q3 29.6M $693M +$646M $23.87 86